pisco_log
banner

Potential Tumor Biomarker: lncRNA SNHG6

Wen Ma, Shu Wang*

Abstract


Small nucleolar RNA host gene 6 (SNHG6), an important member of the lncRNA family, has recently been found to be aberrantly
overexpressed in various malignant tumors. It is widely involved in biological processes such as tumor proliferation, migration, and invasion
through multiple molecular mechanisms. This paper systematically reviews the basic characteristics and molecular mechanisms of SNHG6,
elucidates its research progress and clinical application prospects in lung cancer, breast cancer, urinary system tumors, and digestive system
tumors, aiming to provide a theoretical basis for the early diagnosis and prognostic evaluation of tumors.

Keywords


Long non-coding RNA; Small nucleolar RNA host gene 6; Tumor marker

Full Text:

PDF

Included Database


References


[1] Hyuna, S., et al., Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186

countries. CA Cancer J Clin, 2026. 76(4): p. e70090.

[2] Wang, H.s., et al., Long noncoding RNA SNHG6 mainly functions as a competing endogenous RNA in human tumors. Cancer Cell International, 2020. 20:219(1475-2867 (Print)): p. 10.

[3] Dai, C., et al., Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review). Int J Oncol, 2025. 66(4): p. 29.

[4] Khan, K., et al., LncRNA SNHG6 role in clinicopathological parameters in cancers. Eur J Med Res, 2023. 28(1): p. 363.

[5] Liang, R., et al., SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma. Biomedicine & Pharmacotherapy, 2018. 107: p. 1434-1446.

[6] Khan, M.I. and A. Ahmad, LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction

of EMT. Front Oncol, 2022. 12: p. 1015428.

[7] Liu, Y., et al., Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.

BMC Urol, 2023. 23(1): p. 54.

[8] Zheng, X., et al., SNHG6 Promotes Lipid Metabolic Reprogramming in Hepatocellular Carcinoma via Upregulation of SCD. J Hepatocell Carcinoma, 2026. 13: p. 610313.

[9] Zhang, S., et al., Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis. BMC Cancer,

2020. 20(1): p. 343.

[10] M, Jurkiewicz., et al., Long non-coding RNAs SNHG6 emerge as potential marker in colorectal cancer: Biochim Biophys Acta Rev

Cancer 2024;879(1):189056.




DOI: http://dx.doi.org/10.70711/pmr.v3i11.10326

Refbacks

  • There are currently no refbacks.